The Indian regulatory landscape for cosmetics is undergoing a significant tightening, with national authorities initiating a concerted effort to curb the proliferation of unregistered imported beauty products across the nation. This decisive move by the Drugs Controller General of India (DCGI) signals a pivot towards enhanced consumer protection and market integrity within India’s burgeoning $20 billion beauty and personal care sector, a market projected to reach $30 billion by 2027, driven by rising disposable incomes, urbanization, and increasing beauty consciousness. The directive, issued to state and Union Territory drug regulators, mandates intensified surveillance at all points of entry and throughout the domestic supply chain, targeting products that bypass the mandatory registration process established under the Cosmetics Rules, 2020.
This regulatory escalation is a direct response to a surge in complaints concerning sub-standard and potentially hazardous imported cosmetics, which often enter the market through informal channels, evading standard quality checks and regulatory oversight. The gravity of the situation was recently underscored by actions from state enforcement agencies, such as the Maharashtra Food and Drug Administration (FDA). Its inspections across major urban centers like Pune and Nagpur unearthed instances of counterfeit goods and illegal sales, culminating in the seizure of spurious skin cleaner units in June 2026. Such incidents highlight not only the economic threat posed by counterfeits but also the profound public health risks associated with products that lack verified ingredients and manufacturing standards.
The legal framework underpinning this crackdown is robust, rooted in the Drugs and Cosmetics Act, 1940, and specifically articulated in the Cosmetics Rules, 2020. Rule 12(1) unequivocally states that no cosmetic product shall be imported into India without prior registration with the Central Licensing Authority. This pre-market approval system is designed to ensure that all imported cosmetics meet predefined safety, quality, and labeling standards before they reach Indian consumers. The DCGI’s circular, dated July 22, explicitly called upon state drug regulators and zonal heads of the Central Drugs Standard Control Organisation (CDSCO) to direct their inspectorate staff towards heightened vigilance. Furthermore, port officers have been instructed to maintain a strict vigil, acting as the first line of defense against the illicit entry of unregistered cosmetics. Dr. Rajeev Singh Raghuvanshi, the DCGI, emphasized the critical need for a coordinated approach to effectively stem this unregulated flow.
The stakes are considerable for both consumers and the legitimate industry. India’s cosmetics and personal care segment represents a substantial 26% of the sector’s impressive ₹23,021 crore turnover, as reported by the Indian Direct Selling Association (IDSA) in 2025. This makes it the second-largest contributor to the industry’s overall revenue, underscoring its economic significance. However, the presence of an unregistered grey market not only compromises consumer safety but also undermines the competitive landscape for compliant domestic and international brands. These legitimate players invest heavily in research, development, quality control, and adherence to regulatory standards, only to face unfair competition from products that circumvent these essential processes, often offering lower prices due due to their lack of compliance costs.
The health implications of unregulated cosmetic imports are particularly alarming. Dr. Dinesh Kumar Devaraj, former president of the Indian Association of Dermatologists, Venereologists, and Leprologists (Tamil Nadu), articulates the severe threat posed by these products, which are often "illegitimately spiked with high-potency steroids and dangerous heavy metals like mercury." He pointed to recent incidents in Maharashtra involving smuggled, banned fairness creams carrying "Made in Pakistan" labels, which exemplify the illicit trade. Consumers, often unaware of the dangers, apply these products daily, leading to the systemic absorption of harmful chemicals. This can result in irreversible organ damage, including kidney failure, which frequently manifests only at advanced stages requiring drastic medical interventions like dialysis. The issue extends beyond mere missing registrations to include unapproved formulations sold through unofficial channels, making robust enforcement of Sugam registrations and enhanced port surveillance absolutely critical.
Sugam, CDSCO’s centralized digital platform, plays a pivotal role in streamlining the application process for drugs, medical devices, clinical trials, and cosmetics. It is designed to bring transparency and efficiency to regulatory approvals, ensuring that only products meeting stringent criteria gain market access. The crackdown emphasizes the need to leverage such digital infrastructure to its full potential, creating a traceable and accountable supply chain for imported cosmetics. Globally, leading markets like the European Union, the United States, and China have sophisticated pre-market approval systems that mandate extensive testing and ingredient disclosure, setting a precedent for India’s efforts to align its regulatory practices with international best standards. This move is also consistent with India’s broader "Make in India" initiative, which aims to promote domestic manufacturing and ensure that both locally produced and imported goods adhere to high-quality benchmarks.
The economic impact of this regulatory tightening extends beyond consumer safety. Unregistered imports contribute to a shadow economy, resulting in significant revenue losses for the government through evaded customs duties and taxes. By formalizing the market, the government stands to gain increased tax revenues, which can be reinvested in public services and infrastructure. Moreover, a well-regulated market fosters a more predictable and attractive environment for foreign direct investment from reputable international beauty conglomerates, who prioritize stable regulatory regimes and fair competition. These companies often bring advanced manufacturing technologies, R&D capabilities, and global best practices, further elevating India’s position in the global beauty industry.
Challenges to effective enforcement remain substantial. India’s vast and often porous borders, coupled with the complexity of modern supply chains and the rapid growth of e-commerce, present formidable hurdles. Counterfeiters and illicit traders constantly evolve their methods, making it imperative for regulators to adopt advanced detection technologies and foster greater international cooperation. Consumer awareness also plays a crucial role; while the allure of cheaper products is strong, educating the public about the hidden dangers of unregulated cosmetics is essential to shift demand towards safer, registered alternatives. Industry associations and consumer advocacy groups have a vital role in supporting these educational campaigns and lobbying for sustained regulatory vigilance.
Looking ahead, the DCGI’s current directive is not a one-off measure but rather a clear indication of a sustained commitment to safeguarding public health and ensuring market integrity. This intensified scrutiny is expected to drive greater compliance among importers, potentially leading to a more streamlined and transparent market for beauty products. While the immediate focus is on enforcement, long-term success will hinge on continuous monitoring, adaptation to new market dynamics, and robust international collaboration. By clamping down on unregistered imports, India is not only protecting its citizens from harmful substances but also solidifying its reputation as a responsible and quality-conscious player in the global cosmetics market, ultimately fostering an environment where both consumers and compliant businesses can thrive.
